Aurobindo Pharma Ltd - Stock Price

As on2 Feb 2023

NSE : AUROPHARMA
BSE : 524804
ISIN CODE : INE406A01037
Industry : Pharmaceuticals & Drugs
House : Aurobindo

Aurobindo Pharma Ltd is not traded on BSE/NSE

410.05

-0.64 %-2.65

Previous Close 412.70

Day's Open 411.45

Bid Price (Qty) 410.05 (15)

Offer Price (Qty) 0.00 (0)

Day’s High - Low 414.55 - 408.00

52 Week Range 407.05 - 727.95

Volume Traded (in 000's) 981.01

Value traded (in Cr.) 40.33

PE Ratio (x) 18.08

M Cap (in Cr.)24017.62

Aurobindo Pharma Ltd Stock Price

1d
1w
1m
3m
6m
1yr
3yrs
5yrs

03/02/2017 | 15:19

Current Price8741.20
Open8735.15
High8748.25
Low8707.75
Prev. Close8734.25

Fundamentals

Parameter Values

Market Cap (Rs. in Cr.) 24017.62

Earning Per Share (EPS TTM) (Rs.) 22.68

Price To Earnings (P/E) Ratio 18.08

Book Value Per Share (Rs.) 292.59

Price/Book (MRQ) 1.40

Price/Earning (TTM) 13.78

ROCE (%) 8.52

PAT Margin 12.82

Dividend Yield 2.20

Face Value 1

Financial Summary

Parameter	MAR 22 (`Mn.)	MAR 21 (`Mn.)	YoY %Change
Balance Sheet :
Share Capital	585.90	585.90	0.00
Total Non-Current Liabilities	9031.00	8072.70	11.87
Total Current Liabilities	81559.80	106650.50	-23.53
Total Liabilities	336331.30	334013.10	0.69
Total Non-Current Assets	155104.40	135778.00	14.23
Currents Investments	3788.50	1597.90	137.09
Cash and Bank	41900.10	54742.80	-23.46
Total Current Assets	181226.90	198235.10	-8.58
Total Assets	336331.30	334013.10	0.69
Profit & Loss :
Gross Sales	478117.00	485898.00	-1.60
Net Sales	234555.00	247746.00	-5.32
Total Expenditure	190710.00	194412.00	-1.90
Operating Profit	47071.00	57143.00	-17.63
Profit After Tax	26784.00	53892.00	-50.30

held by Mutual Fund Schemes

Scheme Holding(%)

News & Updates

Peer Comparison

1d
1w
1m
3m
6m
1yr
3yrs
5yrs

More Comparison »

Share Holdings

Description	Percent of Share (%)
Promoters	51.83
Non-Institution	10.96
Mutual Funds/Uti	7.5
Fi/Banks/Insurance	7.15
FII	0
Government	0

More from Share holdings »

The Reliance Group, founded by Dhirubhai H. Ambani , is India's largest private sector enterprise, with businesses in the energy and materials value chain. The flagship company, Reliance Industries Limited, is a Fortune Global 500 company and is the largest private sector company in India.

Dhirubhai Ambani founded Reliance as a textile company and led its evolution as a global leader in the materials and energy value chain businesses. It was in 1957 when he returned to India after a stint with A.Besse& Co., Aden he started yarn trading business from a small 500 sq.ft. office in Masjid Bunder, Mumbai.he set up his brand new mill in Naroda, Gujarat. In 1996 Reliance went on to become the biggest textile brand ‘Only Vimal’. In 1977 the Reliance Textile Industries came with an IPO which was oversubscribed seven times.

Corporate Information

Management Info

Chairman: K Ragunathan
Managing Director: K Nithyananda Reddy
Secretary: B Adi Reddy

Registered Office

Address : Plot No. 2,Maitrivihar ,Ameerpet, Hyderabad,
Telangana-500038 Tel : 040-23736370/23747340 Fax : 040-23741080/23746833 Email : info@aurobindo.com Website : www.aurobindo.com

Registars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 1986. Its today's share price is 409.9. Its current market capitalisation stands at Rs 24017.62 Cr. In the latest quarter, company has reported Gross Sales of Rs. 113503.1 Cr and Total Income of Rs.119759.9 Cr. The company's management includes B Adi Reddy, Girish Vanvari, Savita Mahajan, Avnit Bimal Singh, PV Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, K Nithyananda Reddy, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co